Why the study?
Cardiovascular mortality and morbidity are increased in CKD, prompting an investigation into the effects of statins on patient mortality and cardiac events.
Do statins reduce mortality and cardiac events in adult patients with chronic kidney disease?
Do statins reduce mortality and cardiac events in adult patients with chronic kidney disease?
In a network meta-analysis of CKD patients, pravastatin 40 mg demonstrated the best effect on all-cause mortality and was highly ranked for reducing cardiac events.
Statins reduce mortality and cardiac events in CKD; reinforces first-line use across stages and agents.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Hwang et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: